Lost in Translation: Integrating Medical Interpreters into the Multidisciplinary Team

CME Activity Information
Release Date:	May 30, 2008
Most Recent Review:	May 30, 2008*
Most Recent Update:	May 30, 2008
Date Credit Expires:	May 30, 2010
Time to Complete:	1 hour
Medium:	Internet Online
*Click here to learn more about our review process.

Instructions for Participation

1. Read the following information before beginning the educational activity and click the "Take this course" link at the bottom of the page
2. Study the educational activity
3. Complete the CME quiz and evaluation
4. After successful completion of the CME quiz and evaluation, you will receive the credit or participation certificate

   *The CME quiz and evaluation must be completed by May 30, 2010, in order to receive the credit or participation certificate.

1. Carry out three communication tasks that improve the accuracy of interpretation and increase patient understanding.
2. Provide recommendations for working collaboratively with medical interpreters.
3. Overcome common sources of misunderstanding that result from language and cultural barriers.

All information is submitted and reviewed and found to be scientifically rigorous, based on the best available evidence, fair and balanced, and free of commercial bias. All the recommendations involving clinical medicine in this CME activity are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection and analysis.

Any potential conflicts of interests are resolved via The Oncologist's anonymous peer review process All manuscripts are reviewed by the Editorial Board with ad hoc assistance from two or more external experts in the field. All activity planners, authors, and reviewers are required to submit conflict of interest forms. These forms accompany the activity through the peer review process. Any reviewers who have a conflict of interest are recused. When a reviewer is recused, other suitable reviewers with no self-reported conflicts of interests are selected to conduct the reviews. Editors’ disclosures are published annually online, whereas reviewers’ disclosures are held in confidence within the Editorial Office. All final publication decisions are made by the Editorial Board. The acceptance of a manuscript is based on its originality and importance to the field as assessed by the Editors.

Credentials: Assistant Professor, Department of Medical Oncology, Massachusetts General Hospital, Boston Massachusetts, USA.
Disclosures: The author has indicated no relevant commercial relationships.

Erika Vargas, B.A.

Credentials: Foreign Languages and International Business, Staff Interpreter, Department of Interpreter Services, Massachusetts General Hospital, Boston Massachusetts, USA.
Disclosures: The author has indicated no relevant commercial relationships.

Renzo Hidalgo, M.D.

Credentials: Staff Interpreter, Department of Interpreter Services, Massachusetts General Hospital, Boston Massachusetts, USA.
Disclosures: The author has indicated no relevant commercial relationships.

Marilyn Brier, M.S.W., L.I.C.S.W.

Credentials: Clinical Social Worker, Department of Social Services, Massachusetts General Hospital, Boston Massachusetts, USA.
Disclosures: The author has indicated no relevant commercial relationships.

Lourdes Sanchez, M.A.

Credentials: Manager, Medical Interpreter Services, Department of Interpreter Services, Massachusetts General Hospital, Boston Massachusetts, USA.
Disclosures: The author has indicated no relevant commercial relationships.

Karin Hobrecker, B.A.

Credentials: Interpreter, (Certified, Administrative Office U.S. Courts) Translational Specialist, Department of Interpreter Services, Massachusetts General Hospital, Boston Massachusetts, USA.
Disclosures: The author has indicated no relevant commercial relationships.

Thomas Lynch, M.D.

Credentials: Professor of Medicine, Department of Medical Oncology, Massachusetts General Hospital, Boston Massachusetts, USA.
Disclosures: The author has consulting relationships with AstraZeneca, Bristol-Myers Squibb, and Sanofi-Aventis; all are regarding drug development for lung cancer drugs.

Bruce Chabner, M.D.

Credentials: Professor of Medicine, Department of Medical Oncology, Massachusetts General Hospital, Boston Massachusetts, USA.
Disclosures: The author has indicated no relevant commercial relationships.

• Take this course